The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma

被引:0
|
作者
Kennard, J. A. [1 ]
Stephens, A. J. [1 ]
Manyam, M. [1 ]
Fitzsimmons, C. K. [1 ]
Kilowski, K. A. [1 ]
DeCoff, K. M. [1 ]
Ahmad, S. [1 ]
Pepe, J. W. [1 ]
McKenzie, N. D. [1 ]
Kendrick, J. E. [1 ]
Holloway, R. W. [1 ]
机构
[1] AdventHlth Canc Inst, Orlando, FL USA
关键词
D O I
10.1016/j.ygyno.2020.05.219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
331
引用
收藏
页码:154 / 154
页数:1
相关论文
共 50 条
  • [21] Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
    Bai, Yun
    Du, Ye
    Ye, Pengpeng
    Luo, Yang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] AdoRN Trial: Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly-diagnosed advanced-stage epithelial ovarian cancer
    Gaillard, Stephanie
    Duska, Linda
    Broadwater, Gloria
    McNally, Leah
    Lee, Paula
    Davidson, Brittany
    Previs, Rebecca
    Moss, Haley
    Berchuck, Andrew
    Nixon, Andrew
    Yi, John
    Bookman, Michael
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S61 - S61
  • [23] INTERVAL BETWEEN CYTOREDUCTIVE SURGERY AND ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Timmermans, M.
    van der Aa, M. A.
    Van de Vijver, K. K.
    Kruitwagen, R. F. P. M.
    Sonke, G. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 41 - 41
  • [24] Chemotherapy followed by interval cytoreductive surgery: The most prevalent approach in the upfront treatment of patients with advanced-stage epithelial ovarian cancer in the United States
    Bercow, Alexandra
    Stewart, Taylor
    Bregar, Amy
    Gockley, Allison
    Mazina, Varvara
    Rauh-Hain, J. Alejandro
    Melamed, Alexander
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S347 - S347
  • [25] INTERVAL BETWEEN CYTOREDUCTIVE SURGERY AND ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Timmermans, M.
    van der Aa, M. A.
    Van de Vijver, K. K.
    Kruitwagen, R. F. P. M.
    Sonke, G. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1692 - 1692
  • [26] Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [27] Platinum and taxane intraperitoneal chemotherapy after secondary cytoreductive surgery for recurrent ovarian carcinoma
    Seamon, L. G.
    Seward, S.
    Richardson, D.
    Fowler, J. M.
    Cohn, D. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Platinum and taxane intraperitoneal chemotherapy after secondary cytoreductive surgery for recurrent ovarian carcinoma
    Seamon, L.
    Seward, S.
    Richardson, D.
    Fowler, J.
    Cohn, D.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 374 - 375
  • [29] Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
    Rose, Peter G.
    Java, Janzes J.
    Salani, Ritu
    Geller, Melissa A.
    Secord, Angeles Alvarez
    Tewari, Krishnansu S.
    Bender, David P.
    Mutch, David G.
    Friedlander, Michael L.
    Van Le, Linda
    Method, Michael W.
    Hamilton, Chad A.
    Lee, Roger B.
    Wenham, Robert M.
    Guntupalli, Saketh R.
    Markman, Maurie
    Muggia, Franco M.
    Armstron, Deborah K.
    Bookman, Michael A.
    Burger, Robert A.
    Copeland, Lally J.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (02): : 245 - 254
  • [30] Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer
    Sinukumar, Snita
    Damodaran, Dileep
    Ray, Mukurdipi
    Mehta, Sanket
    Paul, Lista
    Bhatt, Aditi
    EJSO, 2021, 47 (06): : 1427 - 1433